Status:

COMPLETED

Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer

Lead Sponsor:

SCRI Development Innovations, LLC

Collaborating Sponsors:

GlaxoSmithKline

Conditions:

Small Cell Lung Cancer

Carcinoma, Small Cell

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

This proposed phase II trial will investigate weekly topotecan at a higher dose than was used in the previous trials in an attempt to achieve improved response rates and disease control without added ...

Detailed Description

All patients will receive weekly topotecan. Topotecan 6mg/m2 IV weekly x 6 consecutive weeks followed by a 2 week break. Cycles are repeated every 8 weeks, for 3 cycles. Restaging studies will be per...

Eligibility Criteria

Inclusion

  • Extensive small cell lung cancer with progression after one previous chemotherapy or chemotherapy/radiation therapy regimen
  • Measurable or evaluable disease
  • Able to perform activities of daily living with minimal assistance
  • Adequate bone marrow, liver and kidney function
  • May have received no more than 3 previous courses of radiation therapy
  • Give written informed consent prior to study entry

Exclusion

  • Patients with limited stage disease
  • History of a prior malignancy within three years
  • Female patients who are pregnant or are breast feeding
  • Significant history of uncontrolled cardiac disease
  • Myocardial infarction or stroke within six months
  • Symptomatic peripheral vascular disease
  • CNS involvement
  • Serious active infection or underlying medical condition

Key Trial Info

Start Date :

February 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2009

Estimated Enrollment :

38 Patients enrolled

Trial Details

Trial ID

NCT00294190

Start Date

February 1 2006

End Date

July 1 2009

Last Update

December 10 2012

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

Northeast Arkansas Clinic

Jonesboro, Arkansas, United States, 72401

2

Florida Cancer Specialists

Fort Myers, Florida, United States, 33901

3

Watson Clinic Center for Cancer Care and Research

Lakeland, Florida, United States, 33805

4

Florida Hospital Cancer Institute

Orlando, Florida, United States, 32804

Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer | DecenTrialz